| Originator: |
|
MHRA Medical Device Alerts
|
|
|
|
- Care Trusts
- Mental Health Trusts
- Specialists Trusts
- NHS Regional Offices
- Learning Disabilities Trusts
- Mental Health & Social Care Trusts
- Ambulance Trusts
- Mental Health & Learning Disabilities Trusts
- Acute Trusts
- Community Trusts
|
|
|
- Other contacts
- Independent Healthcare Providers (registered with CAS)
- Clinical Commissioning Groups
- Special Health Authorities
|
| Title: |
|
Recommendations for ongoing use of paclitaxel drug coated balloons (DCBs) and implantable drug eluting stents (DESs) in the treatment of patients with peripheral artery disease (PAD)
|
| Broadcast content: |
|
Recommendations following publicised concerns over an increase in patient mortality from two years after treatment.
|
| Additional information: |
|
NHS England Regional offices:
Do not cascade to primary care
|
| Action underway deadline: |
|
11-Jun-2019
|
| Action complete deadline: |
|
02-Jul-2019
|